(Total Views: 901)
Posted On: 07/11/2020 3:58:54 AM
Post# of 30067
Last, it was approved by shareholders
Filing
Submission of Matters to a Vote of Security Holders
On April 29, 2019, the Company held its Annual General Meeting of Shareholders, at which the shareholders of the Company approved the following proposals:
2) The approval of a change of control transaction with Amarantus Bioscience Holdings, Inc. (“Amarantus”), currently a 19.99% shareholder of the Company, whereby the Company will issue to Amarantus an additional thirty percent (30%) of the Company in exchange for obtaining Amarantus’s 80.01% ownership stake in our jointly-owned subsidiary Breakthrough Diagnostics, Inc. (“Breakthrough”), such that upon consummation of the transaction the Company will own 100% of Breakthrough and Amarantus will own 49.99% of the Company;
"The approval of a change of control transaction with Amarantus Bioscience Holdings, Inc"
Votes for - 41,115,107
Votes against - 0
6K Filing on 5.3.19
Filing
Submission of Matters to a Vote of Security Holders
On April 29, 2019, the Company held its Annual General Meeting of Shareholders, at which the shareholders of the Company approved the following proposals:
2) The approval of a change of control transaction with Amarantus Bioscience Holdings, Inc. (“Amarantus”), currently a 19.99% shareholder of the Company, whereby the Company will issue to Amarantus an additional thirty percent (30%) of the Company in exchange for obtaining Amarantus’s 80.01% ownership stake in our jointly-owned subsidiary Breakthrough Diagnostics, Inc. (“Breakthrough”), such that upon consummation of the transaction the Company will own 100% of Breakthrough and Amarantus will own 49.99% of the Company;
"The approval of a change of control transaction with Amarantus Bioscience Holdings, Inc"
Votes for - 41,115,107
Votes against - 0
6K Filing on 5.3.19
(1)
(0)
